Steris Plc STE

NYS: STE | ISIN: IE00BFY8C754 26/07/2024

232,79 USD (+2,30%)

(+2,30%) 26/07/2024

Grafiek Steris Plc

Grafiek Steris Plc

1 dag1d 2,30%
1 week1w 1,76%
1 maand1m 7,55%
3 maanden3m 13,32%
6 maanden6m 7,43%
1 jaar1j 1,31%
5 jaar5j 54,84%

Steris Plc in het nieuws

Toon enkel gratis nieuws

3 juni 2024 · Peak Rock Capital Affiliate Completes Previously Announced Acquisition Of Hufriedygroup · Persbericht

11 april 2024 · Peak Rock Capital Affiliate Signs Definitive Agreement To Acquire Hufriedygroup · Persbericht

20 juni 2023 · BD to Sell Surgical Instrumentation Platform to STERIS · Persbericht

9 maart 2021 · Cantel Medical Reports Strong Financial Results for its Second Quarter Fiscal Year 2021 · Persbericht

9 februari 2021 · CANTEL MEDICAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cantel Medical Corp - CMD · Persbericht

3 februari 2021 · STERIS Announces Leadership Succession Plan · Persbericht

2 februari 2021 · STERIS Announces Financial Results for Fiscal 2021 Third Quarter · Persbericht

19 januari 2021 · STERIS to Host a Conference Call for Fiscal 2021 Third Quarter Financial Results on February 3, 2021 · Persbericht

12 januari 2021 · SHAREHOLDER ALERT: WeissLaw LLP Investigates Cantel Medical Corp. · Persbericht

12 januari 2021 · ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Cantel Medical Corporation · Persbericht

Profiel Steris Plc

Gezondheidstechnologie

Medische Specialiteiten

Productie van medische instrumenten

CEO: Walter Rosebrough

Werknemers: 6.812

Aandelen Steris Plc

Beurswaarde: 22,50 miljard USD

Effecten: 98,85 miljoen

Winst per aandeel (12 maand): PLUS

Koers-winstverhouding: PLUS

Beta: 0,79

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe